MedTrace Logo

Effects of Omega-3 Fatty Acids on Muscle Wasting

NCT04582630 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-10-14

No results posted yet for this study

Summary

The risk of muscle wasting, and sarcopenia is high in the intensive care unit patients and associated with adverse clinical outcomes. The etiology of muscle wasting is multifactorial and medical nutrition therapy plays a key role in treatment and prevention. The purpose of this study is to evaluate the effect of omega-3 fatty acids in the treatment and/or prevention of muscle wasting in critically ill trauma patients.

Conditions

  • Muscle Wasting

Interventions

DIETARY_SUPPLEMENT

omega 3 fatty acid

Participants will take 0.1-0.2 g/kg/day of omega 3 fatty acids for 7 days.

Sponsors & Collaborators

  • Karadeniz Technical University

    lead OTHER

Principal Investigators

  • Ahmet Oguzhan Kucuk, MD · Karadeniz Technical University

  • Melda Kangalgil, MSc · Karadeniz Technical University

  • Kıvanc Oncu, MD · Karadeniz Technical University

  • Serap Ozer Yaman, PhD · Karadeniz Technical University

  • Sekine Turan, MD · Karadeniz Technical University

  • Süleyman Caner Karahan, MD · Karadeniz Technical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2021-07-20
Completion
2021-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582630 on ClinicalTrials.gov